Axoft is a neurotechnology company specializing in developing soft, implantable electronics designed to enhance brain-machine communication. Founded in 2021, the company emerged from research conducted in Dr. Jia Liu's lab at Harvard University. Axoft's innovative brain implants are over 10,000 times softer than conventional materials like plastic and silicone, closely mimicking the mechanical properties of brain tissue. This design aims to improve the stability and longevity of brain-computer interfaces (BCIs). In December 2024, Axoft received approval to begin its first human clinical study, marking a significant milestone in the application of bio-inspired materials for medical use.